Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Droppert V. Marc — Omrix Biopharmaceuticals, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Droppert V. Marc

Droppert V. Marc

Executive Vice President at Omrix Biopharmaceuticals, Inc. · on record since Nov 30, 2007

Insider trading activity of Droppert V. Marc

Transactions on record: 2; since Nov 30, 2007

Open-market buys: 1; $49.9K

Open-market sells: 0

Companies traded: 1; last filing Mar 18, 2008

Figures computed from official regulatory filings — methodology.

Companies where Droppert V. Marc has traded

Omrix Biopharmaceuticals, Inc.2 tx · $49.9K · Mar 18, 2008

Track record of Droppert V. Marc

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Droppert V. Marc

Co-insiders of Droppert V. Marc

Akers Joseph AOmrix Biopharmaceuticals, Inc.
Alperovitz AsafOmrix Biopharmaceuticals, Inc.
BAB BIO VENTURES LLPOmrix Biopharmaceuticals, Inc.
BAB BIO VENTURES NVOmrix Biopharmaceuticals, Inc.
BB BIOVENTURES L POmrix Biopharmaceuticals, Inc.
Bokel GeorgOmrix Biopharmaceuticals, Inc.
Burshtine MichaelOmrix Biopharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

COTTER DOUGLAS AOmrix Biopharmaceuticals, Inc.

ELLBERGER LARRYOmrix Biopharmaceuticals, Inc.

EVNIN LUKEOmrix Biopharmaceuticals, Inc.

GADICKE ANSBERTOmrix Biopharmaceuticals, Inc.

Horowitz BernardOmrix Biopharmaceuticals, Inc.

Mashiach NissimOmrix Biopharmaceuticals, Inc.

MCNAMARA PAMELA WOmrix Biopharmaceuticals, Inc.

MEDICAL PORTFOLIO MANAGEMENT LLCOmrix Biopharmaceuticals, Inc.

MPM ASSET MANAGEMENT INVESTORS 1998 LLCOmrix Biopharmaceuticals, Inc.

MPM BIO VENTURES I LLCOmrix Biopharmaceuticals, Inc.

MPM BIOVENTURES I LPOmrix Biopharmaceuticals, Inc.

MPM BIOVENTURES PARALLEL FUND L POmrix Biopharmaceuticals, Inc.

MPM CAPITAL LPOmrix Biopharmaceuticals, Inc.

Prado NanciOmrix Biopharmaceuticals, Inc.

PRICE FREDRIC DOmrix Biopharmaceuticals, Inc.

RAKIN KEVINOmrix Biopharmaceuticals, Inc.

Romagnoli PhilippeOmrix Biopharmaceuticals, Inc.

SAFFERSTEIN HAROLDOmrix Biopharmaceuticals, Inc.

Stancic AnaOmrix Biopharmaceuticals, Inc.

STEINMETZ MICHAELOmrix Biopharmaceuticals, Inc.

St Peter StevenOmrix Biopharmaceuticals, Inc.

Tang JosephOmrix Biopharmaceuticals, Inc.

Taub RobertOmrix Biopharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Omrix Biopharmaceuticals, Inc.	Mar 18, 2008	Buy	4,000	12.48	$49.9K	SEC
Omrix Biopharmaceuticals, Inc.	Nov 30, 2007	AwardD	60,000	0.00	$0	SEC